A single-center retrospective cohort study analysing prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) as prognostic markers in Metastatic Breast Cancer patients treated with eribulin
Latest Information Update: 14 Jan 2021
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 14 Jan 2021 New trial record
- 01 Jan 2021 Results published in the Anticancer Research